All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
KRTX / Karuna Therapeutics, Inc.
|
|
|
|
|
|
|
|
ESTA / Establishment Labs Holdings Inc.
|
|
|
|
|
|
|
|
CNTX / Context Therapeutics Inc.
|
|
|
|
|
|
|
|
BLU / Bellus Health Inc
|
|
|
|
|
|
|
|
VINC / Vincerx Pharma, Inc.
|
|
|
|
|
|
|
|
NTLA / Intellia Therapeutics, Inc.
|
|
|
|
|
|
|
|
SNDX / Syndax Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
ATHX / Athersys, Inc. Put
|
|
|
|
|
|
|
|
CBAY / CymaBay Therapeutics, Inc.
|
|
|
|
|
|
|
|
ZNTL / Zentalis Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
RCOR.WS / Renovacor, Inc. Warrants, enti Warrants, entitling the holder thereof to purchase one-half (1/2) of a share of common stock at a price of $11.50 per whole share
|
|
|
|
|
|
|
|
CHAQ / Chardan Healthcare Acquisition 2 Corp
|
|
|
|
|
|
|
|
US10806XAD49 / BRIDGEBIO PHARMA INC
|
|
|
|
|
|
|
|
SEER / Seer, Inc. Call
|
|
|
|
|
|
|
|
PRCT / PROCEPT BioRobotics Corporation
|
|
|
|
|
|
|
|
29408N106 / ENVIRONMENTAL IMPACT ACQUISITION CORP
|
|
|
|
|
|
|
|
RFL / Rafael Holdings, Inc. Put
|
|
|
|
|
|
|
|
KYG5960S1241 / Medicus Sciences Acquisition Corp.
|
|
|
|
|
|
|
|
US63009RAD17 / NanoString Technologies Inc
|
|
|
|
|
|
|
|
US761299AB20 / Retrophin Inc Bond
|
|
|
|
|
|
|
|
ARYD / ARYA Sciences Acquisition Corp IV
|
|
|
|
|
|
|
|
LIAN / LianBio - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
US10806XAB82 / Bridgebio Pharma, Inc.
|
|
|
|
|
|
|
|
/ Nautilus Biotechnology Inc
|
|
|
|
|
|
|
|
BEAM / Beam Therapeutics Inc. Call
|
|
|
|
|
|
|
|
PTGX / Protagonist Therapeutics, Inc.
|
|
|
|
|
|
|
|
PTGX / Protagonist Therapeutics, Inc. Put
|
|
|
|
|
|
|
|
ALDX / Aldeyra Therapeutics, Inc.
|
|
|
|
|
|
|
|
NSTG / NanoString Technologies, Inc.
|
|
|
|
|
|
|
|
AUPH / Aurinia Pharmaceuticals Inc. Call
|
|
|
|
|
|
|
|
KDNY / Chinook Therapeutics Inc
|
|
|
|
|
|
|
|
CELU / Celularity Inc. Put
|
|
|
|
|
|
|
|
LSAQ / LifeSci Acquisition II Corp
|
|
|
|
|
|
|
|
MSAC / Medicus Sciences Acquisition Corp - Class A
|
|
|
|
|
|
|
|
PMVP / PMV Pharmaceuticals, Inc. Call
|
|
|
|
|
|
|
|
IOVA / Iovance Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
INO / Inovio Pharmaceuticals, Inc. Call
|
|
|
|
|
|
|
|
ARKG / ARK ETF Trust - ARK Genomic Revolution ETF Call
|
|
|
|
|
|
|
|
CVAC / CureVac N.V. Call
|
|
|
|
|
|
|
|
CRIS / Curis, Inc.
|
|
|
|
|
|
|
|
CRIS / Curis, Inc. Call
|
|
|
|
|
|
|
|
HYPR / Hyperfine, Inc.
|
|
|
|
|
|
|
|
HSAQ / Health Sciences Acquisitions Corp 2
|
|
|
|
|
|
|
|
RCKT / Rocket Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
CYCC / Cyclacel Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
CALA / Calithera Biosciences, Inc.
|
|
|
|
|
|
|
|
HZNP / Horizon Therapeutics Plc
|
|
|
|
|
|
|
|
ARNA / Arena Pharmaceuticals Inc
|
|
|
|
|
|
|
|
ARYE / ARYA Sciences Acquisition Corp V - Class A
|
|
|
|
|
|
|
|
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
KURA / Kura Oncology, Inc.
|
|
|
|
|
|
|
|
VRDN / Viridian Therapeutics, Inc.
|
|
|
|
|
|
|
|
GBT / Global Blood Therapeutics Inc.
|
|
|
|
|
|
|
|
MRTX / Mirati Therapeutics, Inc.
|
|
|
|
|
|
|
|
NVAX / Novavax, Inc. Put
|
|
|
|
|
|
|
|
IMTXW / Immatics N.V. - Equity Warrant
|
|
|
|
|
|
|
|
MDGL / Madrigal Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
BPMC / Blueprint Medicines Corporation
|
|
|
|
|
|
|
|
CRSP / CRISPR Therapeutics AG Call
|
|
|
|
|
|
|
|
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
MRNA / Moderna, Inc. Put
|
|
|
|
|
|
|
|
RPTX / Repare Therapeutics Inc.
|
|
|
|
|
|
|
|
SPY / SPDR S&P 500 ETF Put
|
|
|
|
|
|
|
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
SAVA / Cassava Sciences, Inc. Put
|
|
|
|
|
|
|
|
TVTX / Travere Therapeutics, Inc.
|
|
|
|
|
|
|
|
RLAY / Relay Therapeutics, Inc. Call
|
|
|
|
|
|
|
|
CYTK / Cytokinetics, Incorporated
|
|
|
|
|
|
|
|
LNTH / Lantheus Holdings, Inc.
|
|
|
|
|
|
|
|
LNTH / Lantheus Holdings, Inc. Put
|
|
|
|
|
|
|
|
ACRS / Aclaris Therapeutics, Inc.
|
|
|
|
|
|
|
|
SWTX / SpringWorks Therapeutics, Inc.
|
|
|
|
|
|
|
|
SWTX / SpringWorks Therapeutics, Inc. Put
|
|
|
|
|
|
|
|
CLDX / Celldex Therapeutics, Inc.
|
|
|
|
|
|
|
|
CERE / Cerevel Therapeutics Holdings, Inc.
|
|
|
|
|
|
|
|
NARI / Inari Medical, Inc.
|
|
|
|
|
|
|
|
MORF / Morphic Holding, Inc.
|
|
|
|
|
|
|
|
BBIO / BridgeBio Pharma, Inc.
|
|
|
|
|
|
|
|
XENE / Xenon Pharmaceuticals Inc.
|
|
|
|
|
|
|
|